05/01/2026
The pharmaceutical industry exhibits extraordinarily high profitability, often surpassing estimates for illicit drug trades, while employing sophisticated mechanisms such as offshore tax havens to obscure financial transparency. This opacity not only facilitates tax avoidance but also perpetuates inequities in global health access.
This "recipe" serves corporations indefinitely, while millions face unaffordable medicines. High margins, concealed via offshores, enable reinvestment in lobbying rather than innovation, echoing cartel behaviors but with legal impunity.
Health diplomacy—encompassing multi-level negotiations among stakeholders to shape global health policy—remains a crucial yet often underutilized tool in tackling systemic health inequities.
https://www.publicdiplomacy.institute/